FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain
Publishing timestamp: 2025-01-14 16:49:23
Summary
The FTC found that the nation's three largest pharmacy benefit managers marked up prices of certain medicines at their affiliated pharmacies by hundreds or thousands of percent, generating billions in revenue. The companies are accused of steering more profitable prescriptions to their own pharmacies and overcharging patients. The FTC has sued the PBMs for their practices.
Sentiment: NEGATIVE
Keywords: unitedhealth group inc, business, cigna corp, federal trade commission, pharmaceuticals, breaking news: politics, cvs health corp, business news, health care industry, politics,